Cargando…

MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer

BACKGROUND: MAPK8IP2 is one of the JNK-interacting proteins (JIPs) family members, and is involved in the regulation of the JNK and P38 MAPK signaling pathways. MAPK8IP2 has been reported to be closely associated with several cancers. However, the biological function of MAPK8IP2 in prostate cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Zhenhao, He, Wenrui, Jiang, Yi, Jiang, Hao, Cheng, Xiaofeng, Deng, Wen, Zhou, Xiaochen, Zhang, Cheng, Wang, Gongxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650804/ https://www.ncbi.nlm.nih.gov/pubmed/36357836 http://dx.doi.org/10.1186/s12885-022-10259-2

Ejemplares similares

The slope associated with nadir prostate‐specific antigen is prognostically significant in men with hormone‐sensitive prostate cancer after primary androgen deprivation therapy
por: Zhenhao, Zeng, et al.
Publicado: (2022)

LINC00467 Promotes Prostate Cancer Progression via M2 Macrophage Polarization and the miR-494-3p/STAT3 Axis
por: Jiang, Hao, et al.
Publicado: (2021)

Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2023)

Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2022)

Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study
por: Cheng, Xiaofeng, et al.
Publicado: (2021)

Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity
por: Huang, Jian, et al.
Publicado: (2022)

Loss of MAPK8IP3 Affects Endocytosis in Neurons
por: Snead, Amanda M., et al.
Publicado: (2022)

Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
por: Li, Xuwen, et al.
Publicado: (2023)

Functional Preservation and Oncologic Control following Robot-Assisted versus Laparoscopic Radical Prostatectomy for Intermediate- and High-Risk Localized Prostate Cancer: A Propensity Score Matched Analysis
por: Deng, Wen, et al.
Publicado: (2021)

Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo
por: Yu, Feng, et al.
Publicado: (2020)

Optimal placement of flexible ureteral access sheath in retrograde intrarenal surgery
por: Chen, Yujun, et al.
Publicado: (2023)

Functional and Oncological Outcomes Following Robot-Assisted and Laparoscopic Radical Prostatectomy for Localized Prostate Cancer With a Large Prostate Volume: A Retrospective Analysis With Minimum 2-Year Follow-Ups
por: Deng, Wen, et al.
Publicado: (2021)

Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer
por: Zhou, Xiaochen, et al.
Publicado: (2018)

Transvesical Retzius-Sparing Versus Standard Robot-Assisted Radical Prostatectomy: A Retrospective Propensity Score-Adjusted Analysis
por: Deng, Wen, et al.
Publicado: (2021)

STK3 promotes gastric carcinogenesis by activating Ras-MAPK mediated cell cycle progression and serves as an independent prognostic biomarker
por: Chen, Bonan, et al.
Publicado: (2021)

Circ-APBB1IP as a Prognostic Biomarker Promotes Clear Cell Renal Cell Carcinoma Progression Through The ERK1/2 Signaling Pathway
por: Mo, Jierong, et al.
Publicado: (2020)

Prognostic value of CtIP/RBBP8 expression in breast cancer
por: Soria-Bretones, Isabel, et al.
Publicado: (2013)

SEC23A Is an Independent Prognostic Biomarker in Bladder Cancer Correlated With MAPK Signaling
por: Zeng, Bin, et al.
Publicado: (2021)

Evaluation of PKM2 and MAPK8IP2 Polymorphism in Ameloblastic Carcinoma: A Retrospective Quantitative Study
por: Khodayari, Abbas, et al.
Publicado: (2012)

Prognostic role of genetic biomarkers in clinical progression of prostate cancer
por: Alvarez-Cubero, Maria Jesus, et al.
Publicado: (2015)

Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis
por: Lu, Yaoyong, et al.
Publicado: (2017)

Prostate Tumor Overexpressed 1 Is a Novel Prognostic Marker for Hepatocellular Carcinoma Progression and Overall Patient Survival
por: Chen, Shu-Peng, et al.
Publicado: (2015)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

XBP1s promotes the development of lung adenocarcinoma via the p-JNK MAPK pathway
por: Jiang, Hongxia, et al.
Publicado: (2022)

Robot-assisted retroperitoneal laparoscopic partial nephrectomy without hilar occlusion VS classic robot-assisted retroperitoneal laparoscopic partial nephrectomy: A retrospective comparative study
por: Guo, Ju, et al.
Publicado: (2019)

The HIF/PHF8/AR axis promotes prostate cancer progression
por: Tong, D, et al.
Publicado: (2016)

Transvesical Versus Posterior Approach to Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Retrospective Comparison With a 12-Month Follow-Up
por: Deng, Wen, et al.
Publicado: (2021)

CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells
por: Liu, Xiaoqiang, et al.
Publicado: (2019)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer
por: Jiang, Yi, et al.
Publicado: (2022)

Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021)

Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
por: Yang, Xiaochen, et al.
Publicado: (2021)

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2023)

A Reliable Parameter to Standardize the Scoring of Stem Cell Spheres
por: Zhou, Xiaochen, et al.
Publicado: (2015)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
por: Feng, Yuanfa, et al.
Publicado: (2023)

Current Progresses of Exosomes as Cancer Diagnostic and Prognostic Biomarkers
por: Huang, Tao, et al.
Publicado: (2019)

Prognostic values of serum IP-10 and IL-17 in Patients with Pulmonary Tuberculosis
por: Chen, Yung-Che, et al.
Publicado: (2011)

IP4GS: Bringing genomic selection analysis to breeders
por: Li, Tong, et al.
Publicado: (2023)

Autophagy-related genes are potential diagnostic and prognostic biomarkers in prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2020)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tn6h6hdnu458vplik98979jq0i